NEWSROOM

MEDIA CONTACTS

 

media@galderma.com

Christian Marcoux, Chief Communications Officer: +41 76 315 26 50

Sébastien Cros, Corporate Communications Director: +41 79 529 59 85 

Filter news by date

2 . 14 . 2022

 

Galderma launches Alastin Skincare® ReFORM & RePAIR COMPLEX with TriHex Technology® designed to assist with recovery from surgical body procedures

1 . 5 . 2022

 

Galderma successfully completes acquisition of ALASTIN Skincare®

12 . 14 . 2021

 

Addressing gaps in acne management: New expert recommendations to optimize patient care

12 . 7 . 2021

 

Maria Teresa Hilado to join Galderma’s Advisory Committee

12 . 3 . 2021

 

Galderma announces new data demonstrating the positive anti-inflammatory effect and mode of action of nemolizumab in patients with moderate to severe Prurigo Nodularis

11 . 25 . 2021

 

Galderma to acquire award-winning ALASTIN Skincare® enhancing its integrated dermatology platform to continue delivering the best experience to patients

9 . 30 . 2021

 

RESTYLANE®, the original stabilized hyaluronic acid filler, celebrates 25 years of unmatched achievement

9 . 29 . 2021

 

Galderma presents new nemolizumab data at EADV reinforcing rapid onset of action and consistent relief of symptoms for people with prurigo nodularis and atopic dermatitis

9 . 28 . 2021

 

Galderma to unveil ground-breaking data from across its leading dermatology portfolio and showcase major update for sensitive skincare brand CETAPHIL® at the 2021 EADV Congress

9 . 27 . 2021

 

Galderma and CETAPHIL® Announce Renewed Commitment to Environmental Sustainability and Social Impact Through New Clear Skies Initiative

9 . 23 . 2021

 

Galderma announces exclusive agreement with Sofregen to develop the next generation of biostimulator fillers using silk-based technology

9 . 9 . 2021

 

Galderma to present new data from leading aesthetics portfolio and launch RESTYLANE® EYELIGHT™ at AMWC 2021